CHAMPIONS ONCOLOGY ($CSBR) posted quarterly earnings results for Q4 2026 on Monday, July 27th. The company reported earnings of -$0.05 per share, beating estimates of -$0.05 by $0.00. The company also reported revenue of $13,840,000, beating estimates of $13,143,720 by $696,280.
You can see Quiver Quantitative's $CSBR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CHAMPIONS ONCOLOGY Hedge Fund Activity
We have seen 5 institutional investors add shares of CHAMPIONS ONCOLOGY stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MINK BROOK ASSET MANAGEMENT LLC added 31,033 shares (+38.6%) to their portfolio in Q1 2026, for an estimated $178,439
- O'SHAUGHNESSY ASSET MANAGEMENT, LLC removed 13,031 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $74,928
- MORGAN STANLEY added 12,641 shares (+5.5%) to their portfolio in Q1 2026, for an estimated $72,685
- MILLENNIUM MANAGEMENT LLC removed 10,203 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $58,667
- RENAISSANCE TECHNOLOGIES LLC removed 9,300 shares (-6.0%) from their portfolio in Q1 2026, for an estimated $53,475
- ACADIAN ASSET MANAGEMENT LLC removed 8,672 shares (-28.9%) from their portfolio in Q1 2026, for an estimated $49,864
- BANK OF NEW YORK MELLON CORP removed 5,135 shares (-19.2%) from their portfolio in Q1 2026, for an estimated $29,526
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
